HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
16 hedge funds and large institutions have $2.43M invested in Hepion Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$66.1K | |
| 2 | +$41K | |
| 3 | +$3.61K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$369 |
Top Sellers
| 1 | -$337K | |
| 2 | -$32.9K | |
| 3 | -$16.7K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$16.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.97K |